Zolinza

Vorinostat

6.8 High risk

Zolinza & Product use in unapproved indication

22.1%

of users reported Product use in unapproved indication

50.0%

also reported Hospitalization

53.3%

are men

Most common medical consequences

Hospitalization
50.0%
Severe reaction
50.0%

Have you experienced any negative side effects from this medication?

Zolinza: general information

Most common side effects (9)

Most commonly affected ages

10 - 19 years
7.1%
20 - 29 years
<0.1%
30 - 39 years
<0.1%
40 - 49 years
<0.1%
50 - 59 years
9.3%
60 - 69 years
44.3%
70 - 79 years
39.3%
On this page
Zolinza & Product use in unapproved indication
Zolinza: general information